AU2003207315A1 - Treatment of muscle damage - Google Patents

Treatment of muscle damage

Info

Publication number
AU2003207315A1
AU2003207315A1 AU2003207315A AU2003207315A AU2003207315A1 AU 2003207315 A1 AU2003207315 A1 AU 2003207315A1 AU 2003207315 A AU2003207315 A AU 2003207315A AU 2003207315 A AU2003207315 A AU 2003207315A AU 2003207315 A1 AU2003207315 A1 AU 2003207315A1
Authority
AU
Australia
Prior art keywords
treatment
muscle damage
muscle
damage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003207315A
Inventor
Nicholas Beaumont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2003207315A1 publication Critical patent/AU2003207315A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1223—Phosphotransferases with a nitrogenous group as acceptor (2.7.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/03—Phosphotransferases with a nitrogenous group as acceptor (2.7.3)
    • C12Y207/03002—Creatine kinase (2.7.3.2)
AU2003207315A 2002-02-14 2003-02-14 Treatment of muscle damage Abandoned AU2003207315A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0203552.5 2002-02-14
GB0203552A GB0203552D0 (en) 2002-02-14 2002-02-14 Peptide growth factor
PCT/GB2003/000657 WO2003068949A1 (en) 2002-02-14 2003-02-14 Treatment of muscle damage

Publications (1)

Publication Number Publication Date
AU2003207315A1 true AU2003207315A1 (en) 2003-09-04

Family

ID=9931107

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003207315A Abandoned AU2003207315A1 (en) 2002-02-14 2003-02-14 Treatment of muscle damage

Country Status (3)

Country Link
AU (1) AU2003207315A1 (en)
GB (1) GB0203552D0 (en)
WO (1) WO2003068949A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0202906D0 (en) 2002-02-07 2002-03-27 Univ London Prevention of myocardial damage
WO2006097764A1 (en) * 2005-03-18 2006-09-21 Ucl Business Plc Mecano growth factor peptides and their use
WO2006097682A1 (en) * 2005-03-18 2006-09-21 Ucl Business Plc Mechano growth factor peptides and their use
EP3265118B1 (en) * 2015-03-06 2019-08-28 Centre National De La Recherche Scientifique Use of creatine kinase and derived peptides thereof to relief pain
CN105254766B (en) * 2015-10-26 2018-10-16 中国航天员科研训练中心 Application of the Mecano growth factor MGF E domain peptides in regulation and control memory related gene and miRNA expression

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995012662A1 (en) * 1993-11-02 1995-05-11 Genzyme Corporation Method of producing recombinant dimeric enzyme
US5981249A (en) * 1998-02-05 1999-11-09 Spectral Diagnostics, Inc. Single-chain polypeptides comprising creatine kinase M and creatine kinase B
EP1311704A2 (en) * 2000-05-30 2003-05-21 Medigene AG Novel target genes for diseases of the heart

Also Published As

Publication number Publication date
GB0203552D0 (en) 2002-04-03
WO2003068949A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
AU2002257936A1 (en) Methods of well treatment
AU2003278361A1 (en) Method of water treatment
IL164266A0 (en) Treatment of gastroparesis
AU2003283257A1 (en) Scalp treatment
AU2003230952A1 (en) Treatment of mucositis
AUPS328002A0 (en) Water treatment
AU2003293099A1 (en) Treatment of dna damage related disorders
AU2003260778A1 (en) Treatment of pipes
AU2003268923A1 (en) Treatment of aml
AU2003222065A1 (en) Chemiluminescent treatment of acne
AU2002952086A0 (en) Treatment of osteoarthritis
GB0210741D0 (en) Methods of therapy
AU2003207315A1 (en) Treatment of muscle damage
AU2002952129A0 (en) Treatment of hypersensitivity conditions
AU2003270615A1 (en) Treatment of steatosis using hyperthermia
GB0217493D0 (en) Novel methods of treatment
AU2002951913A0 (en) Method of treatment
GB0208897D0 (en) New method of treatment
GB0221712D0 (en) Methods of treatment
AU2003208900A1 (en) L-carnitine for treatment of hearing loss
GB0213198D0 (en) Method of treatment
AUPS219902A0 (en) Methods of treatment
GB0207091D0 (en) Method of treatment
AUPS079602A0 (en) Method of treatment
AU2002953042A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase